← Leaderboards
Donald W. Parsons
Baylor College Of Medicine
$9,398,880
Attributed
$23,684,067
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,684,067 · 2
By mechanism
U01$22,141,840 · 1
K12$1,542,227 · 1
Top collaborators
- Sharon Emma Plon14 shared
- Amy Lynn Mcguire8 shared
- Carl E Allen2 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- David G. Poplack$17,817,283
- Sharon Emma Plon$39,994,796
- Susan M Blaney$10,519,074
- Anthony Johnson$983,976
- Carl E Allen$9,873,324
Others in their field
Top investigators on “Texas”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
- Gary D Acton · University Of California-Davis$320,373,312
- Richard A Gibbs · Baylor College Of Medicine$277,873,103
- Daniel Stanzione · Arizona State University$168,178,740
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
Research focus
TexasScholarshipMedicineCollegePediatric OncologyParentsCancer PatientMalignant Childhood NeoplasmInterviewGenomicsExomeHealth PolicyBasePediatric OncologistHigh RiskSocial ImplicationMedicalMalignant NeoplasmsReportingEthicsCancer GeneticsChildDisclosureSampling
Grant awards (16)
PEDIATRIC ONCOLOGY CLINICAL RESEARCH TRAINING PROGRAM$810,000
K12 · FY2025 · CA
PEDIATRIC ONCOLOGY CLINICAL RESEARCH TRAINING PROGRAM$732,227
K12 · FY2024 · CA
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: The KidsCanSeq Study$1,696,158
U01 · FY2021 · HG
Measuring Perceptions of Utility of Clinical Genome Sequencing: Instrument Testing and Validation$278,317
U01 · FY2021 · HG
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: The KidsCanSeq Study$2,603,257
U01 · FY2020 · HG
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: The KidsCanSeq Study$3,283,327
U01 · FY2019 · HG
Adolescent and Young Adult Cancer Patients Attitudes toward and Decision-Making Preferences about Clinical Genome Sequencing$159,680
U01 · FY2019 · HG
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: The KidsCanSeq Study$3,453,099
U01 · FY2018 · HG
CSER Perceived Utility Supplement$383,691
U01 · FY2018 · HG
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: The KidsCanSeq Study$2,801,395
U01 · FY2017 · HG
Incorporation of Genomic Sequencing into Pediatric Cancer Care$1,152,619
U01 · FY2016 · HG
Incorporation of Genomic Sequencing into Pediatric Cancer Care$1,152,619
U01 · FY2015 · HG
Incorporation of Genomic Sequencing into Pediatric Cancer Care$1,675,628
U01 · FY2014 · HG
Incorporation of Genomic Sequencing into Pediatric Cancer Care$1,673,317
U01 · FY2013 · HG
Incorporation of Genomic Sequencing into Pediatric Cancer Care$1,760,708
U01 · FY2012 · HG
Incorporation of Genomic Sequencing into Pediatric Cancer Care$68,025
U01 · FY2012 · HG